RYDER SYSTEM INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that RYDER SYSTEM INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.67B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $12.64B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $11.78B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $12.01B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $9.66B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $8.42B | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | $2.28B | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $2.22B | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $2.24B | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $2.18B | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $499.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $489.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $406.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $867.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $519.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | ($122.00M) | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | ($53.49M) | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | ($91.46M) | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $75.22M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $45.32M | Feb 27, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.47B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.48B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.42B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.42B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.19B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $1.04B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $907.45M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $849.41M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $870.92M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $804.23M | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.59B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $2.27B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $2.35B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $2.31B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $2.18B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $2.18B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $2.14B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $1.72B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.63B | Feb 27, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.39B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $16.67B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $15.78B | Feb 12, 2025 |
| FY2024 | Dec 31, 2022 | $14.40B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $13.84B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $12.93B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $14.48B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $13.35B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $11.73B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $10.91B | Feb 21, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.34B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $13.56B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $12.71B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $11.46B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $11.04B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $10.68B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $12.00B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $10.81B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $8.62B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $8.85B | Feb 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.05B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $3.12B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $3.07B | Feb 11, 2026 |
| FY2025 | Dec 31, 2022 | $2.94B | Feb 11, 2026 |
| FY2024 | Dec 31, 2021 | $2.80B | Feb 12, 2025 |
| FY2023 | Dec 31, 2020 | $2.26B | Feb 20, 2024 |
| FY2022 | Dec 31, 2019 | $2.48B | Feb 15, 2023 |
| FY2021 | Dec 31, 2018 | $2.54B | Feb 17, 2022 |
| FY2020 | Dec 31, 2017 | $2.45B | Feb 19, 2021 |
| FY2019 | Dec 31, 2016 | $2.06B | Feb 27, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.15B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.16B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $940.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $861.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $571.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $475.25M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $475.03M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $475.21M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $395.50M | Feb 21, 2019 |
| FY2018 | Dec 31, 2016 | $386.77M | Feb 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.57B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $2.64B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $2.55B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $2.52B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $2.27B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $1.91B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $2.18B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $2.34B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $2.47B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $1.83B | Feb 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $198.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $154.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $204.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $267.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $234.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $151.29M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $73.58M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $68.11M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $78.35M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $58.80M | Feb 20, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $7.77B | Feb 12, 2025 |
| FY2023 | Dec 31, 2023 | $7.13B | Feb 20, 2024 |
| FY2022 | Dec 31, 2022 | $6.33B | Feb 15, 2023 |
| FY2021 | Dec 31, 2021 | $6.56B | Feb 17, 2022 |
| FY2020 | Dec 31, 2020 | $6.59B | Feb 19, 2021 |
| FY2019 | Dec 31, 2019 | $7.90B | Feb 27, 2020 |
| FY2018 | Dec 31, 2018 | $6.62B | Feb 21, 2019 |
| FY2017 | Dec 31, 2017 | $5.40B | Feb 20, 2018 |
| FY2016 | Dec 31, 2016 | $5.37B | Feb 14, 2017 |
| FY2015 | Dec 31, 2015 | $5.48B | Feb 12, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 11 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | 17 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 9 | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | (1) | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | (1) | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 11 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | 17 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 9 | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | (1) | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | (1) | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 39.42M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 42.08M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | 43.90M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 46.29M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | 53.79M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | 53.73M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | 53.28M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 53.12M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 52.96M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | 53.46M | Feb 20, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $145.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $135.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $128.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $123.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $122.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $119.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $116.47M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $111.86M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $95.81M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $91.04M | Feb 21, 2019 |